We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

86 hedge funds and large institutions have $32.3M invested in Spectrum Pharmaceuticals Inc in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 20 increasing their positions, 25 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,271% more call options, than puts

Call options by funds: $480K | Put options by funds: $35K

15% less funds holding

Funds holding: 10186 (-15)

20% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 25

42% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 31

65% less capital invested

Capital invested by funds: $92.5M → $32.3M (-$60.2M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
86
Holders Change
-15
Holders Change %
-14.85%
% of All Funds
1.45%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
18
Increased
20
Reduced
25
Closed
31
Calls
$480K
Puts
$35K
Net Calls
+$445K
Net Calls Change
+$97K

SPPI Hedge Fund Activity: Q2 2022 in Review

86 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2022, worth a combined $32.3M — down 65% from $92.5M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of SPPI and 18 opened new positions — a net loss of 13 holders — while 25 trimmed existing stakes and 20 added.

The largest buyer was Millennium Management, adding an estimated $1.7M. The largest seller was BlackRock, cutting an estimated $6.97M.

  • 86 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2022, down from 101 in Q1 2022.
  • Funds reported $32.3M of Spectrum Pharmaceuticals Inc stock for Q2 2022, down 65% quarter-over-quarter.
  • 18 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2022 and 31 closed out, a net change of -13 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q2 2022 was Millennium Management, an estimated $1.7M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q2 2022 was BlackRock, an estimated $6.97M sold.

Based on aggregated 13F filings for Q2 2022.